The Nobel Prize-winning scientific innovation underlying the COVID-19 vaccine proved to be a notable financial boon for the ...

University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine royalties, writes John George ...

The university filed a lawsuit against BioNTech four months ago, claiming that the company licensed vaccine technology ...

plus another $15 million to fund BioNTech and University of Pennsylvania vaccine alliance research for another three years as part of the settlement. Finally, the company will contribute $52 million ...

In Review 805 articles and counting2,837 new Instagram followers1,771 new Bluesky followers It was quite a year. Join us in ...

Wall St finishes down after sell-off at end of strong holiday-shortened week December 28, 2024 BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of ...

France reports bird flu on two farms, losing disease-free status Healthcare & Pharmaceuticalscategory· December 31, 2024 BioNTech has entered into two separate settlement agreements with the U.S ...

In 2009, Pfizer faced more than $2 billion in legal settlement payments over marketing ... vaccine approved – via its collaboration with BioNTech – it feels like we're only on the cusp of ...

The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...

The proposed settlement filed in federal court earlier this week still needs to be approved by a judge, but here are a few things to know about the case and the privacy issues that it raised.